BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11581371)

  • 1. Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform.
    Vorberg I; Chan K; Priola SA
    J Virol; 2001 Nov; 75(21):10024-32. PubMed ID: 11581371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155.
    Priola SA; Chabry J; Chan K
    J Virol; 2001 May; 75(10):4673-80. PubMed ID: 11312338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting interactions between prion protein isoforms.
    Caughey B; Baron GS
    Biochem Soc Trans; 2002 Aug; 30(4):565-9. PubMed ID: 12196138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein.
    Xiong LW; Raymond LD; Hayes SF; Raymond GJ; Caughey B
    J Neurochem; 2001 Nov; 79(3):669-78. PubMed ID: 11701770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro.
    Lawson VA; Priola SA; Wehrly K; Chesebro B
    J Biol Chem; 2001 Sep; 276(38):35265-71. PubMed ID: 11466311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells.
    Priola SA; Chesebro B
    J Virol; 1995 Dec; 69(12):7754-8. PubMed ID: 7494285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
    Horiuchi M; Caughey B
    EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cells expressing anchorless prion protein are resistant to scrapie infection.
    McNally KL; Ward AE; Priola SA
    J Virol; 2009 May; 83(9):4469-75. PubMed ID: 19225008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal properties of prion protein with insertional mutations in different cell types.
    Priola SA; Chesebro B
    J Biol Chem; 1998 May; 273(19):11980-5. PubMed ID: 9565627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation influences cross-species formation of protease-resistant prion protein.
    Priola SA; Lawson VA
    EMBO J; 2001 Dec; 20(23):6692-9. PubMed ID: 11726505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion protein and species barriers in the transmissible spongiform encephalopathies.
    Priola SA
    Biomed Pharmacother; 1999; 53(1):27-33. PubMed ID: 10221165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes.
    Baron GS; Wehrly K; Dorward DW; Chesebro B; Caughey B
    EMBO J; 2002 Mar; 21(5):1031-40. PubMed ID: 11867531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generating Bona Fide Mammalian Prions with Internal Deletions.
    Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; BĂ©ringue V; Rezaei H; Dron M
    J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of the disulfide bond in prion protein conversion.
    Herrmann LM; Caughey B
    Neuroreport; 1998 Aug; 9(11):2457-61. PubMed ID: 9721914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.
    Raymond GJ; Hope J; Kocisko DA; Priola SA; Raymond LD; Bossers A; Ironside J; Will RG; Chen SG; Petersen RB; Gambetti P; Rubenstein R; Smits MA; Lansbury PT; Caughey B
    Nature; 1997 Jul; 388(6639):285-8. PubMed ID: 9230438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of protease-resistant prion protein in cell-free systems.
    Caughey B
    Curr Issues Mol Biol; 2000 Jul; 2(3):95-101. PubMed ID: 11471561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain-specific effects of reducing agents on the cell-free conversion of recombinant prion protein into a protease-resistant form.
    Imamura M; Kato N; Okada H; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T
    Microbiol Immunol; 2011 Sep; 55(9):633-40. PubMed ID: 21645053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines.
    Caughey WS; Raymond LD; Horiuchi M; Caughey B
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12117-22. PubMed ID: 9770449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells.
    Caughey B; Neary K; Buller R; Ernst D; Perry LL; Chesebro B; Race RE
    J Virol; 1990 Mar; 64(3):1093-101. PubMed ID: 1968104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation.
    Moore RA; Herzog C; Errett J; Kocisko DA; Arnold KM; Hayes SF; Priola SA
    Protein Sci; 2006 Mar; 15(3):609-19. PubMed ID: 16452616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.